Technical Feasibility of Online Adaptive Stereotactic Treatments in the Abdomen on a Robotic Radiosurgery System

Overview

Journal Phys Imaging Radiat Oncol

Specialty Oncology

Date 2022 Aug 5

PMID 35928600

Authors

Maaike T W Milder

Alba Magallon-Baro

Wilhelm den Toom

Erik de Klerck

Lorne Luthart

Joost J Nuyttens

Mischa S Hoogeman

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Stereotactic body radiotherapy (SBRT) has been proven to be beneficial for several disease sites in the (lower) abdomen. However, the quality of the treatment plan, based on a single planning computed tomography (CT), can be compromised due to large inter-fraction motion of the target and organs at risk (OARs) in this anatomical region. The aim of this study was to investigate the feasibility of online adaptive SBRT treatments on a robotic radiosurgery system and to record estimated total treatment times.

Materials And Methods: For two disease sites, locally advanced pancreatic cancer (LAPC) and oligometastatic lymph nodes, four patients with repeat CTs were included in the feasibility study. Quick treatment plan templates were generated based on the planning CT and validated by running them on the plan and fraction CTs. For two cases a dummy run was performed and the individual steps were timed. Dose delivery was the largest contributor to the total treatment time, followed by contour adaptation.

Results: Running the quick plan templates resulted in plans similar to unrestricted plans, obeying the OAR constraints. The dummy runs showed that online adaptive treatments were completed in 64 to 83 min respectively for oligometastases and LAPC, comparable to other clinically available solutions.

Conclusions: This study showed the feasibility of online re-planning for two challenging disease sites within a clinically acceptable time frame on a robotic radiosurgery system, making use of commercially available elements that are not integrated by the vendor.

Citing Articles

First-in-Men Online Adaptive Robotic Stereotactic Body Radiation Therapy: Toward Ultrahypofractionation for High-Risk Prostate Cancer Patients.

Brand V, Milder M, Christianen M, de Vries K, Hoogeman M, Incrocci L Adv Radiat Oncol. 2025; 10(2):101701.

PMID: 39866592 PMC: 11758839. DOI: 10.1016/j.adro.2024.101701.

Precision requirements in stereotactic arrhythmia radioablation for ventricular tachycardia.

Fast M, Lydiard S, Boda-Heggemann J, Tanadini-Lang S, Muren L, Clark C Phys Imaging Radiat Oncol. 2023; 28:100508.

PMID: 38026083 PMC: 10679852. DOI: 10.1016/j.phro.2023.100508.

References

Ten Haken R, Forman J, Heimburger D, Gerhardsson A, McShan D, Schoeppel S . Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder. Int J Radiat Oncol Biol Phys. 1991; 20(6):1317-24. DOI: 10.1016/0360-3016(91)90244-x. View

Lee M, Simeonov A, Stanescu T, Dawson L, Brock K, Velec M . MRI evaluation of normal tissue deformation and breathing motion under an abdominal compression device. J Appl Clin Med Phys. 2021; 22(2):90-97. PMC: 7882116. DOI: 10.1002/acm2.13165. View

Kontaxis C, Bol G, Lagendijk J, Raaymakers B . A new methodology for inter- and intrafraction plan adaptation for the MR-linac. Phys Med Biol. 2015; 60(19):7485-97. DOI: 10.1088/0031-9155/60/19/7485. View

Loi M, Magallon-Baro A, Suker M, van Eijck C, Sharma A, Hoogeman M . Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk. Radiother Oncol. 2019; 134:67-73. DOI: 10.1016/j.radonc.2019.01.020. View

Willigenburg T, de Muinck Keizer D, Peters M, Claes A, Lagendijk J, de Boer H . Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear accelerator. Clin Transl Radiat Oncol. 2021; 27:50-56. PMC: 7822780. DOI: 10.1016/j.ctro.2021.01.002. View

Milder M, Alber M, Sohn M, Hoogeman M . Commissioning and clinical implementation of the first commercial independent Monte Carlo 3D dose calculation to replace CyberKnife M6™ patient-specific QA measurements. J Appl Clin Med Phys. 2020; 21(11):304-311. PMC: 7700940. DOI: 10.1002/acm2.13046. View

Sibolt P, Andersson L, Calmels L, Sjostrom D, Bjelkengren U, Geertsen P . Clinical implementation of artificial intelligence-driven cone-beam computed tomography-guided online adaptive radiotherapy in the pelvic region. Phys Imaging Radiat Oncol. 2021; 17:1-7. PMC: 8057957. DOI: 10.1016/j.phro.2020.12.004. View

Grimbergen G, Eijkelenkamp H, Heerkens H, Raaymakers B, Intven M, Meijer G . Intrafraction pancreatic tumor motion patterns during ungated magnetic resonance guided radiotherapy with an abdominal corset. Phys Imaging Radiat Oncol. 2022; 21:1-5. PMC: 8715205. DOI: 10.1016/j.phro.2021.12.001. View

McPartlin A, Li X, Kershaw L, Heide U, Kerkmeijer L, Lawton C . MRI-guided prostate adaptive radiotherapy - A systematic review. Radiother Oncol. 2016; 119(3):371-80. DOI: 10.1016/j.radonc.2016.04.014. View

10.

Lim-Reinders S, Keller B, Al-Ward S, Sahgal A, Kim A . Online Adaptive Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017; 99(4):994-1003. DOI: 10.1016/j.ijrobp.2017.04.023. View

11.

Kunzel L, Nachbar M, Hagmuller M, Gani C, Boeke S, Zips D . First experience of autonomous, un-supervised treatment planning integrated in adaptive MR-guided radiotherapy and delivered to a patient with prostate cancer. Radiother Oncol. 2021; 159:197-201. DOI: 10.1016/j.radonc.2021.03.032. View

12.

Henke L, Kashani R, Robinson C, Curcuru A, DeWees T, Bradley J . Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen. Radiother Oncol. 2017; 126(3):519-526. DOI: 10.1016/j.radonc.2017.11.032. View

13.

Werensteijn-Honingh A, Jurgenliemk-Schulz I, Gadellaa-Van Hooijdonk C, Sikkes G, Vissers N, Winkel D . Impact of a vacuum cushion on intrafraction motion during online adaptive MR-guided SBRT for pelvic and para-aortic lymph node oligometastases. Radiother Oncol. 2020; 154:110-117. DOI: 10.1016/j.radonc.2020.09.021. View

14.

Kilby W, Dooley J, Kuduvalli G, Sayeh S, Maurer Jr C . The CyberKnife Robotic Radiosurgery System in 2010. Technol Cancer Res Treat. 2010; 9(5):433-52. DOI: 10.1177/153303461000900502. View

15.

Olberg S, Green O, Cai B, Yang D, Rodriguez V, Zhang H . Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer. Radiat Oncol. 2018; 13(1):51. PMC: 5866525. DOI: 10.1186/s13014-018-1000-7. View

16.

de Muinck Keizer D, van der Voort van Zyp J, de Groot-van Breugel E, Raaymakers B, Lagendijk J, de Boer H . On-line daily plan optimization combined with a virtual couch shift procedure to address intrafraction motion in prostate magnetic resonance guided radiotherapy. Phys Imaging Radiat Oncol. 2021; 19:90-95. PMC: 8327343. DOI: 10.1016/j.phro.2021.07.010. View

17.

McNair H, Joyce E, OGara G, Jackson M, Peet B, Huddart R . Radiographer-led online image guided adaptive radiotherapy: A qualitative investigation of the therapeutic radiographer role. Radiography (Lond). 2021; 27(4):1085-1093. PMC: 8497277. DOI: 10.1016/j.radi.2021.04.012. View

18.

van Sornsen de Koste J, Palacios M, Bruynzeel A, Slotman B, Senan S, Lagerwaard F . MR-guided Gated Stereotactic Radiation Therapy Delivery for Lung, Adrenal, and Pancreatic Tumors: A Geometric Analysis. Int J Radiat Oncol Biol Phys. 2018; 102(4):858-866. DOI: 10.1016/j.ijrobp.2018.05.048. View

19.

Antico M, Prinsen P, Cellini F, Fracassi A, Isola A, Cobben D . Real-time adaptive planning method for radiotherapy treatment delivery for prostate cancer patients, based on a library of plans accounting for possible anatomy configuration changes. PLoS One. 2019; 14(2):e0213002. PMC: 6394960. DOI: 10.1371/journal.pone.0213002. View

20.

van Herk M, Bruce A, Kroes A, Shouman T, Touw A, Lebesque J . Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys. 1995; 33(5):1311-20. DOI: 10.1016/0360-3016(95)00116-6. View